ApiotiX Technologies

Introducing Apiotix gel: A New Innovation for Skin Health We are pleased to announce the completion of Apiotix gel, a novel product developed over the past year of testing and creation using our patented technology. This innovative formulation is designed to meet the growing demand for scientifically-backed and multifunctional solutions for skin health. Key Features of Apiotix Gel: - Specifically created to repair skin barriers, promote skin regeneration, and soothe irritated skin - Developed using our patented technology to ensure high quality and innovation - Formulated to the highest standards of efficacy and safety Apiotix gel represents our latest scientific advancement in skin health. It offers a unique solution that combines advanced research with practical benefits for sensitive skin. It took a year of dedicated research and development to bring this product to life. At Apiotix Technology, we are committed to taking skin health a step further with continuous innovation and are open to partnerships and collaboration opportunities.

Exciting Collaboration Announcement! ApiotiX Technologies is thrilled to announce collaboration with NextGen Actives for the North American market! This strategic partnership signifies a major step forward in our commitment to expand and innovate within the skincare industry. Our efforts have garnered recognition, and we are confident that the synergy between our scientific approach and the deep industry expertise and knowledge of Elham Tavasoli, Ph.D. CEO and founder of NextGen Actives, will lead to groundbreaking developments. Together, we're poised to introduce innovative scientific based solutions like the next-generation retinol alternative.

Apiotix Mission: Redefining Skincare with PAPE, the Next-Generation Retinol Alternative With the global retinol market projected to reach $1.87 billion by 2030 (70% in skincare & cosmetics), introducing effective alternatives presents a significant market opportunity. Having published clinical trial results on the anti-wrinkle efficacy and safety of the first standardized PAPE from propolis (https://lnkd.in/d-WF73YB), we have a groundbreaking development poised to revolutionize the skincare industry as a viable alternative to retinol. PAPE's appeal lies in its ability to meet consumer expectations of efficacy and safety. It is positioned to attract a broad market segment, including individuals with sensitive skin who cannot use traditional retinol products. The EU will soon limit final product retinoids, opening the need for a new practical solution, and PAPE fits excellently. Apiotix invites skincare professionals, researchers, and industry leaders to explore PAPE's potential. Through collaborative efforts, we can fully realize PAPE's transformative impact on the skincare industry. Join us in redefining skincare and advancing the future of anti-aging solutions. Apiotix is committed to not just following industry trends but creating them. With PAPE, we are setting new benchmarks for skincare.

🌟 Predstavljamo tim ApiotiX Technologies! 🌟 Danas predstavljamo još jedan tim iz našeg programa predakceleracije NetHub Catalyst, koji provodimo u suradnji s EIT Health. Apiotix Technologies posvećen je istraživanju i razvoju inovativnih proizvoda kao alternativa antibioticima kako bi poboljšali zdravlje ljudi, životinja, biljaka i njihovog zajedničkog okoliša. Inspirirani su borbom protiv jednog od najvećih globalnih zdravstvenih problema - antimikrobne rezistencije. Njihov revolucionarni proizvod, Apimast, temelji se na standardiziranom ekstraktu propolisa koji pokazuje iznimnu učinkovitost u liječenju mastitisa kod mliječnih krava, ali i drugih infekcija i upala kod životinja i ljudi. Tim se sastoji od: 👩🔬 Jelena Šuran (CEO) – nekadašnja izvanredna profesorica veterinarske farmakologije na Veterinarskom fakultetu Sveučilišta u Zagrebu, sada je uspješna poduzetnica i direktorica u Apiotixu. 👨⚕️ Bozo Radic (COO) - Liječnik s doktoratom iz farmakologije i iskustvom u vođenju poslovanja kroz firmu Hedera. Ima bogato iskustvo i stručnost u gastroenterologiji. 💼 Vlado Sliskovic (CFO) – Financijski stručnjak, ekonomist; diplomirao je na Webster University i magistrirao financije na EADA Business School. S njihovim naporima u unapređenju veterinarske medicine, Apiotix Technologies ima potencijal značajno doprinijeti zdravlju i dobrobiti životinja. S ponosom ih podržavamo u njihovoj misiji i daljnjem razvoju. 👏 Pratite nas za više informacija o našim ostalim timovima i inovacijama koje stvaramo zajedno s EIT Healthom! #NetHubCatalyst #EITHealth #HealthTech #Innovation #AntibioticAlternatives #HealthcareInnovation #Startup

Labena Ventures, the accelerator that fueled Apiotix's startup journey, is on the lookout for the next wave of innovators. 🚀 Applications are now extended until April 26th! If you're in biotech, healthtech, pharmatech, food, or environment, seize this opportunity! Let's shape the future together! Apply here: www.labenaventures.com  #LabenaVentures #InnovationInCEEC #StartupOpportunity

Another winning pitch for ApiotiX Technologies! 🚀 This time, we presented our innovative wound-healing Apiotix gel made of synergistic natural polymers! 🔬 This is a non-antibiotic wound healing game changer - for both humans & animals! 🏃♀️ 🤸♀️ 🐕 🐎 Big thanks to NetHub - health innovation for their tremendous support in our innovation journey - which has just begun! 💪

Exciting news from Ghent! We pitched at #DIAH2024 and we won in the selection of best emerging startups! We would like to thank all the organizers and our colleagues for supporting us on this journey! 🚀

When the product works, it works! 🚀

Startup ApiotiX Technologies has launched a new propolis-based #skincare ingredient that it said can "address unmet industry needs" and "potentially reduce the reliance on common preservatives in skin care formulations". Find out more here... https://lnkd.in/dWneP7A2